Epetraborole

Drug identity checked against registry records

Also recorded as AN2-501971

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseNCT05327803ANTXPhase 2, Phase 3Terminated2024-12-18Actual
Phase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraNCT07891533ANTXPhase 2Not yet recruiting2029-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.